Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Return on Equity (2016 - 2025)

Guided Therapeutics' Return on Equity history spans 14 years, with the latest figure at 0.47% for Q3 2025.

  • For Q3 2025, Return on Equity rose 2.0% year-over-year to 0.47%; the TTM value through Sep 2025 reached 0.47%, up 2.0%, while the annual FY2024 figure was 0.56%, 49.0% down from the prior year.
  • Return on Equity for Q3 2025 was 0.47% at Guided Therapeutics, down from 0.48% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.73% in Q2 2023 and bottomed at 0.27% in Q2 2021.
  • The 5-year median for Return on Equity is 0.49% (2025), against an average of 0.67%.
  • The largest annual shift saw Return on Equity soared 137bps in 2023 before it tumbled -123bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.31% in 2021, then soared by 400bps to 1.57% in 2022, then crashed by -40bps to 0.94% in 2023, then crashed by -47bps to 0.49% in 2024, then fell by -4bps to 0.47% in 2025.
  • Per Business Quant, the three most recent readings for GTHP's Return on Equity are 0.47% (Q3 2025), 0.48% (Q2 2025), and 0.49% (Q1 2025).